North America Glucose Monitoring Devices Market Forecast to 2030 - Regional Analysis - By Type (Continuous Glucose Monitoring Devices and Self-Glucose Monitoring Devices), Application (Type 1 Diabetes and Type 2 Diabetes), Testing Type (Fingertip Testing

North America Glucose Monitoring Devices Market Forecast to 2030 - Regional Analysis - By Type (Continuous Glucose Monitoring Devices and Self-Glucose Monitoring Devices), Application (Type 1 Diabetes and Type 2 Diabetes), Testing Type (Fingertip Testing and Alternate Site Testing), and End User (Healthcare Settings and Self/Homecare)

The North America glucose monitoring devices market is expected to grow from US$ 5,987.78 million in 2022 to US$ 14,409.58 million by 2030. It is estimated to grow at a CAGR of 11.6% from 2022 to 2030.

Rapid Technological Advancements in Glucose Monitoring Devices Fuel North America Glucose Monitoring Devices Market

Products with advanced technologies offer more effective benefits in diabetes treatment. As the prevalence of diabetes increases worldwide, the demand for more products with advancements also accelerates. Thus, researchers have been carrying out research activities resulting in product innovations over the years. There are many methods to deliver insulin into the body, such as needles, insulin pens, and insulin pumps. Insulin pumps are small, computerized diabetes management devices connected with a cannula under the skin to deliver a slow, continuous insulin level. The individual can control the program depending on the requirements. Optimal diabetes management depends on accurate glucose monitoring devices. The increasing advancements in glucose monitoring devices have resulted in smaller required blood volumes with improved accuracy. The ability to transfer data between the blood glucose meter and glucose monitoring devices has also been improved. The increasing advancements in blood glucose monitoring technology have improved accuracy, smaller required blood volumes, and the ability to transfer data between the blood glucose meter and glucose monitoring devices. In June 2022, Abbott announced a new bio wearable that continuously monitors glucose and ketone levels in one sensor. Thus, the technological advancements coupled with the increasing influx of new products are expected to propel the market growth over the forecast years.

North America Glucose Monitoring Devices Market Overview

The North America North America glucose monitoring devices market has been segmented into the US, Canada, and Mexico. The market growth in this region is attributed to the rising diabetic prevalence, and increasing geriatric population are main factors positively influencing the growth of the market. Additionally, technological advancements in monitoring devices further enhances the overall market growth during 2022-2030.

North America Glucose Monitoring Devices Market Revenue and Forecast to 2030 (US$ Million)

North America Glucose Monitoring Devices Market Segmentation

The North America glucose monitoring devices market is segmented into type, application, testing site, end- user, and country.

Based on type, the North America glucose monitoring devices market is segmented into continuous glucose monitoring devices and self-glucose monitoring devices. The self-glucose monitoring devices segment held a larger share of the North America glucose monitoring devices market in 2022.

Based on application, the North America glucose monitoring devices market is segmented into type 1 diabetes and type 2 diabetes. The type 2 diabetes segment held a larger share of the North America glucose monitoring devices market in 2022.

Based on testing site, the North America glucose monitoring devices market is segmented into fingertip testing and alternate site testing. The fingertip testing segment held a larger share of the North America glucose monitoring devices market in 2022.

Based on end user, the North America glucose monitoring devices market is segmented into healthcare setting and self/homecare. The self/homecare segment held a larger share of the North America glucose monitoring devices market in 2022.

Based on country, the North America glucose monitoring devices market is segmented int o the US, Canada, and Mexico. The US dominated the North America glucose monitoring devices market in 2022.

B. Braun SE, F. Hoffmann-La Roche Ltd, LifeScan Inc, Medtronic Plc, Abbott Laboratories, Ypsomed Holding AG, Senseonics Holdings Inc, Nipro Corp, and GE HealthCare Technologies Inc, and Terumo Corp are some of the leading companies operating in the North America glucose monitoring devices market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America glucose monitoring devices market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in North America glucose monitoring devices market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.